In the past week, ZTS stock has gone down by -3.86%, with a monthly decline of -0.08% and a quarterly surge of 4.64%. The volatility ratio for the week is 2.54%, and the volatility levels for the last 30 days are 2.23% for Zoetis Inc The simple moving average for the past 20 days is -2.55% for ZTS’s stock, with a -1.33% simple moving average for the past 200 days.
Is It Worth Investing in Zoetis Inc (NYSE: ZTS) Right Now?
Zoetis Inc (NYSE: ZTS) has a higher price-to-earnings ratio of 33.70x compared to its average ratio. ZTS has 36-month beta value of 0.87. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 7 as “overweight,” 7 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ZTS is 455.91M, and currently, short sellers hold a 1.16% ratio of that float. The average trading volume of ZTS on August 06, 2024 was 2.28M shares.
ZTS) stock’s latest price update
The stock of Zoetis Inc (NYSE: ZTS) has decreased by -3.20 when compared to last closing price of 180.59.Despite this, the company has seen a loss of -3.86% in its stock price over the last five trading days. zacks.com reported 2024-08-02 that Investors with an interest in Medical – Drugs stocks have likely encountered both United Therapeutics (UTHR) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
Analysts’ Opinion of ZTS
Many brokerage firms have already submitted their reports for ZTS stocks, with BTIG Research repeating the rating for ZTS by listing it as a “Buy.” The predicted price for ZTS in the upcoming period, according to BTIG Research is $220 based on the research report published on July 25, 2024 of the current year 2024.
Stifel, on the other hand, stated in their research note that they expect to see ZTS reach a price target of $215, previously predicting the price at $195. The rating they have provided for ZTS stocks is “Buy” according to the report published on January 12th, 2024.
Jefferies gave a rating of “Buy” to ZTS, setting the target price at $230 in the report published on December 19th of the previous year.
ZTS Trading at -0.32% from the 50-Day Moving Average
After a stumble in the market that brought ZTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.42% of loss for the given period.
Volatility was left at 2.23%, however, over the last 30 days, the volatility rate increased by 2.54%, as shares sank -0.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.61% upper at present.
During the last 5 trading sessions, ZTS fell by -3.86%, which changed the moving average for the period of 200-days by +0.32% in comparison to the 20-day moving average, which settled at $179.36. In addition, Zoetis Inc saw -11.43% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZTS starting from Lagano Roxanne, who sale 923 shares at the price of $151.17 back on Apr 18 ’24. After this action, Lagano Roxanne now owns 14,800 shares of Zoetis Inc, valued at $139,530 using the latest closing price.
Lagano Roxanne, the Executive Vice President of Zoetis Inc, sale 923 shares at $173.33 during a trade that took place back on Mar 18 ’24, which means that Lagano Roxanne is holding 15,723 shares at $159,984 based on the most recent closing price.
Stock Fundamentals for ZTS
Current profitability levels for the company are sitting at:
- 0.37 for the present operating margin
- 0.69 for the gross margin
The net margin for Zoetis Inc stands at 0.27. The total capital return value is set at 0.26. Equity return is now at value 50.06, with 17.02 for asset returns.
Based on Zoetis Inc (ZTS), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at 0.36. The debt to equity ratio resting at 1.3. The interest coverage ratio of the stock is 13.29.
Currently, EBITDA for the company is 3.56 billion with net debt to EBITDA at 1.34. When we switch over and look at the enterprise to sales, we see a ratio of 9.68. The receivables turnover for the company is 6.75for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.33.
Conclusion
To put it simply, Zoetis Inc (ZTS) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
